Insider Trading Alert - VLO, LGND And DAR Traded By Insiders

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Yesterday, March 20, 2014, 98 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $251.68 to $253,000,000.00.

Highlighted Stocks Traded by Insiders:

Valero Energy Corporation (VLO) - FREE Research Report

Klesse William R who is COB and CEO at Valero Energy Corporation sold 51,659 shares at $54.57 on March 20, 2014. Following this transaction, the COB and CEO owned 1.2 million shares meaning that the stake was reduced by 4.24% with the 51,659-share transaction.

The shares most recently traded at $54.66, up $0.09, or 0.16% since the insider transaction. Historical insider transactions for Valero Energy Corporation go as follows:

  • 4-Week # shares sold: 53,426
  • 12-Week # shares sold: 53,426
  • 24-Week # shares sold: 53,426

The average volume for Valero Energy Corporation has been 8.3 million shares per day over the past 30 days. Valero Energy Corporation has a market cap of $28.9 billion and is part of the basic materials sector and energy industry. Shares are up 7.82% year-to-date as of the close of trading on Thursday.

Valero Energy Corporation operates as an independent petroleum refining and marketing company in the United States, Canada, the Caribbean, the United Kingdom, and Ireland. It operates through two segments, Refining and Ethanol. The stock currently has a dividend yield of 1.82%. The company has a P/E ratio of 11.1. Currently there are 10 analysts that rate Valero Energy Corporation a buy, no analysts rate it a sell, and 3 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on VLO - FREE

TheStreet Quant Ratings rates Valero Energy Corporation as a buy. The company's strengths can be seen in multiple areas, such as its solid stock price performance, impressive record of earnings per share growth, compelling growth in net income, attractive valuation levels and good cash flow from operations. We feel these strengths outweigh the fact that the company shows low profit margins. Get the full Valero Energy Corporation Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Ligand Pharmaceuticals (LGND) - FREE Research Report

Davis Todd C who is Director at Ligand Pharmaceuticals sold 7,500 shares at $79.57 on March 20, 2014. Following this transaction, the Director owned 32,536 shares meaning that the stake was reduced by 18.73% with the 7,500-share transaction.

The shares most recently traded at $74.98, down $4.59, or 6.12% since the insider transaction. Historical insider transactions for Ligand Pharmaceuticals go as follows:

  • 4-Week # shares bought: 293
  • 4-Week # shares sold: 6,000
  • 12-Week # shares bought: 293
  • 12-Week # shares sold: 6,000
  • 24-Week # shares bought: 293
  • 24-Week # shares sold: 12,499

The average volume for Ligand Pharmaceuticals has been 349,200 shares per day over the past 30 days. Ligand Pharmaceuticals has a market cap of $1.6 billion and is part of the health care sector and drugs industry. Shares are up 47.66% year-to-date as of the close of trading on Thursday.

Ligand Pharmaceuticals Incorporated, a biotechnology company, engages in the acquisition and development of royalty revenue generating assets in the United States. The company has a P/E ratio of 185.1. Currently there are 4 analysts that rate Ligand Pharmaceuticals a buy, no analysts rate it a sell, and 1 rates it a hold.

Exclusive Offer: Get the latest Stock Analysis on LGND - FREE

TheStreet Quant Ratings rates Ligand Pharmaceuticals as a buy. The company's strengths can be seen in multiple areas, such as its compelling growth in net income, revenue growth, notable return on equity, good cash flow from operations and expanding profit margins. Although no company is perfect, currently we do not see any significant weaknesses which are likely to detract from the generally positive outlook. Get the full Ligand Pharmaceuticals Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Darling International (DAR) - FREE Research Report

Griffin Martin W. who is EVP - Chief Operations Officer at Darling International sold 3,647 shares at $20.01 on March 20, 2014. Following this transaction, the EVP - Chief Operations Officer owned 643,939 shares meaning that the stake was reduced by 0.56% with the 3,647-share transaction.

The shares most recently traded at $19.79, down $0.22, or 1.09% since the insider transaction.

The average volume for Darling International has been 1.2 million shares per day over the past 30 days. Darling International has a market cap of $3.2 billion and is part of the industrial goods sector and materials & construction industry. Shares are down 5.8% year-to-date as of the close of trading on Thursday.

Darling International Inc. provides rendering, used cooking oil, and bakery residual recycling and recovery solutions to the food industry. The company operates in two segments, Rendering and Bakery. The company has a P/E ratio of 22.0. Currently there are 3 analysts that rate Darling International a buy, no analysts rate it a sell, and 1 rates it a hold.

Exclusive Offer: Get the latest Stock Analysis on DAR - FREE

TheStreet Quant Ratings rates Darling International as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures and increase in stock price during the past year. We feel these strengths outweigh the fact that the company has had sub par growth in net income. Get the full Darling International Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

null

More from Markets

Lowe's Snags Ex-Home Depot Exec as CEO; ISPs Face Competitive Threat -- ICYMI

Lowe's Snags Ex-Home Depot Exec as CEO; ISPs Face Competitive Threat -- ICYMI

Dow Slips 178 Points; S&P 500 and Nasdaq Also Decline

Dow Slips 178 Points; S&P 500 and Nasdaq Also Decline

Legal Weed Sales in California Are Off to a Less Than Smokin' Start

Legal Weed Sales in California Are Off to a Less Than Smokin' Start

Owner of Moviepass Sees Stock Plummet

Owner of Moviepass Sees Stock Plummet

Ford, GM Gain as China Slashes Auto Import Tariffs

Ford, GM Gain as China Slashes Auto Import Tariffs